Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from Incyte Corporation, Pharmacyclics LLC, and Mallinckrodt.

Community Practice Connections™: New Therapies for Better Patient Outcomes in GVHD: Integration of Recent Data Sets Into Clinical Practice

Release Date: April 27, 2020
Expiration Date: April 27, 2021

Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of graft-versus-host disease (GVHD), with a forward-looking perspective on how new and novel agents might impact clinical practice. An overview of disease pathology, updates to diagnosing and staging, current available therapies, and new concepts for GVHD treatment and prevention will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated throughout text-based elements.

Acknowledgement of Support

This activity is supported by an educational grant from Incyte Corporation, Pharmacyclics LLC, and Mallinckrodt.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is intended for hematologists, medical oncologists, researchers, and investigators who treat or are interested in the treatment of patients with hematologic malignancies. Other allied healthcare professionals, including nurse practitioners, physician assistants, and nurses involved in the treatment and management of patients with hematologic malignancies are also invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Discuss advancements in the understanding of the pathobiology of GVHD to better inform clinical decision making.
  • Compare and contrast the efficacy and safety of available and emerging therapies for the treatment of patients with acute and chronic GVHD.
  • Implement current and emerging prophylactic strategies for the prevention of GVHD.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


James L. M. Ferrara, MD, DSc
James L. M. Ferrara, MD, DSc
Ward-Coleman Chair in Cancer Medicine
Professor and Director, Hematologic Malignancies
Translational Research Center
The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Other: IP—Patent for biomarkers of acute GVHD.

Madan H. Jagasia, MBBS, MSCI, MMHC
Madan H. Jagasia, MBBS, MSCI, MMHC
Chief Medical Officer
Professor of Medicine
Vanderbilt-Ingram Cancer Center
Nashville, TN

Disclosures: Madan H. Jagasia, MBBS, MSCI, MMHC, has no relevant financial relationship with commercial interest to disclose.

Muna Qayed, MD, MsCR
Muna Qayed, MD, MsCR
Professor of Pediatrics
Emory University School of Medicine
Program Medical Director of Cell Therapy
Aflac Cancer & Blood Disorders Center
Children’s Healthcare of Atlanta
Atlanta, GA

Disclosures: Consultant: Novartis advisory board, 2019.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By